Biotage, LLC

Charlotte, NC Doing business as Biotage

UEI
DBDJB8EBJZ85
CAGE
1ULZ8
Primary NAICS
423490 Other Professional Equipment and Supplies Merchant Wholesalers
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
10430 Harris Oaks Blvd c, Charlotte, NC 28269, USA
Website
biotage.com
Founded
1999
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Biotage, LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
The purpose of this PR is to procure new analytical instrumentation (3 automated solid phase extractors and 2… Contract · 68HE0826P0049 EPA Region 8 $182,230
Biotage turbovap LV system Contract · 75F40126P00273 Food and Drug Administration $30,031
Niddk - initiator+ alstra - microwave peptide synthesizer US/JP Contract · 75N98026P01531 Office of Logisitics and Acquisition Operations $80,793
Nitrogen blowdown solvent evaporation systems Contract · 36C25726P0536 Veterans Integrated Service Network 17 $38,345
Lsasd capital equipment - biotage systems: spedex 5000 (X4) Contract · 68HE0526P0053 EPA Region 5 $286,354

About Biotage, LLC

Biotage, LLC, doing business as Biotage, is a Charlotte, North Carolina-based manufacturer of analytical chemistry equipment and laboratory consumables that sells specialized instruments and related services to federal agencies as a prime contractor on 442 full-and-open purchase orders and service contracts with no set-aside designations. Biotage is a for-profit limited liability company that has held federal vendor status since 2001 and qualifies as a small business under NAICS 334516 (Analytical Laboratory Instrument Manufacturing).

Biotage's federal capability footprint centers on specialized analytical chemistry instrumentation, sample preparation workstations, chromatography systems, evaporators, and extraction equipment. Representative work includes a $286 thousand purchase order from EPA Region 5 (April 2026) for four SPEDEX 5000 systems; a $167 thousand service and maintenance agreement with the National Center for Advancing Translational Sciences (June 2024) covering microwaves, V-10S, and Isolera systems used by multiple NCATS research groups; a $216 thousand delivery of TurboVap evaporators to CDC Pittsburgh (June 2022); and a $143 thousand flash purification chromatography system with automated mass-directed fraction collection to NCATS (August 2022) supporting the Antiviral Program for Pandemics. Equipment maintenance and service contracts recur across the portfolio, spanning preventative maintenance packages, extended warranties, and multi-year support agreements.

Customer concentration is pronounced within the Department of Health and Human Services. The top five customer sub-agencies account for 31 percent of awards by count but 46 percent of combined potential value. CDC Pittsburgh leads in both measures with 38 awards ($2 million combined potential value), followed by NIH Clinical Center (17 awards, $1.5 million), FDA (39 awards, $1.1 million), CDC Office of Acquisition Services (31 awards, $993 thousand), and NIH National Center for Advancing Translational Sciences (8 awards, $887 thousand). Environmental Protection Agency regional offices (Regions 1–9, Office of Research and Development, and Office of Land and Emergency Management) account for a secondary concentration of 30 awards. Biotage has worked with 76 distinct customer agencies, but HHS agencies dominate both volume and value; defense and civilian non-HHS agencies collectively account for smaller order volumes, principally Navy and Army medical and technical commands.

Biotage operates on a single named parent vehicle: the NIH Indefinite Delivery Contract HHSN269201700015I, under which seven task orders carry $201 thousand in combined potential value. The remaining 435 awards are standalone purchase orders or service agreements, typically in the $10 thousand to $200 thousand range, issued directly by customer agencies without an overarching IDIQ or blanket purchase agreement. This vehicle structure reflects Biotage's posture as a direct manufacturer supplying commercial off-the-shelf or lightly customized laboratory equipment through transactional spot purchases rather than large umbrella contracts.

Activity declined materially from 2022 onward. Biotage received 24 awards in 2022, 14 in 2023, 13 in 2024, 7 in 2025, and 1 award in 2026 (as of April). Combined potential value across all 442 awards is $14.1 million, of which $12.7 million (90 percent) has been obligated. Only three awards with ultimate completion dates in the next twenty-four months carry a combined potential value of $116 thousand, representing minimal recompete exposure. The steep year-over-year decline and sparse forward pipeline suggest either reduced federal customer demand for Biotage's product lines, inventory sufficiency among existing customers, or customer migration to alternative vendors or contract mechanisms.

Biotage does not maintain a subcontractor footprint; all 442 awards are prime contracts in which Biotage directly manufactures and delivers equipment. The vendor does not appear on federal awards as a sub-recipient or subcontractor. Category concentration by NAICS reinforces the analytical chemistry equipment focus: 289 awards are classified under Analytical Laboratory Instrument Manufacturing, with secondary concentrations in Pump and Pumping Equipment Manufacturing (27 awards) and repair and maintenance (23 awards). By PSC code, 272 awards fall under Laboratory Equipment and Supplies, 51 under maintenance and repair, 32 under medical and surgical instruments, and 17 under chemicals. This tight category clustering confirms a vendor profile narrowly specialized in selling analytical instruments and consumables into government research, environmental, and public health laboratories.

Quick answers

What is Biotage, LLC's UEI?

Biotage, LLC's Unique Entity ID (UEI) in SAM.gov is DBDJB8EBJZ85.

What is Biotage, LLC's CAGE code?

Biotage, LLC's CAGE code is 1ULZ8.

What is Biotage, LLC's primary NAICS code?

Biotage, LLC's primary NAICS code is 423490 (Other Professional Equipment and Supplies Merchant Wholesalers).

Where is Biotage, LLC located?

Biotage, LLC's physical address in SAM.gov is 10430 Harris Oaks Blvd c, Charlotte, NC 28269, USA.

Is Biotage, LLC registered in SAM.gov?

Yes. Biotage, LLC's SAM.gov registration is active through April 9, 2027.

What is Biotage, LLC's most recent federal award?

Biotage, LLC's most recent federal contract award is The purpose of this PR is to procure new analytical instrumentation (3 automated solid phase extractors and 2… (68HE0826P0049), from EPA Region 8, on September 28, 2026.

On GovTribe

See Biotage, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors